NEW YORK, NY – AUGUST 22, 2013 – TCT 2013 (Transcatheter Cardiovascular Therapeutics), the annual scientific symposium of the Cardiovascular Research Foundation (CRF), will be the setting for the announcement of significant clinical trial findings, symposia and discussion among global leaders in interventional cardiology of the most innovative strategies for treating patients with cardiovascular disease and other conditions.
TCT 2013 will be held in San Francisco October 27-November 1.
Through the presentation of first report and late breaking clinical trial data, featured trials and scientific abstracts, TCT again promises to make major medical and scientific news by showcasing advances in valve replacement, stent construction and design, pharmacologic therapies and technological breakthroughs in catheter based vascular treatments.
And, this year, TCT will mark 25 years of innovation with a day-long look back at the significant contributions that interventional cardiology has made to patients with cardiovascular disease, as well as an inspiring look ahead at new therapies being developed for the not too distant future.
Members of the media may apply for press credentials for TCT 2013 at: http://www.tctconference.com/press/press-registration-form.html
Every year, TCT features major medical research breakthroughs and gathers leading researchers and clinicians to present and discuss the latest evidence-based research developments and clinical guidelines in interventional cardiovascular medicine. TCT delivers state-of-the-art techniques and training to physicians and healthcare professionals around the world. To learn more about the conference, visit: http://www.tctconference.com.
The Cardiovascular Research Foundation (CRF) is an independent, academically focused nonprofit organization dedicated to improving the survival and quality of life for people with cardiovascular disease through research and education. Since its inception in 1991, CRF has played a major role in realizing dramatic improvements in the lives of countless numbers of patients by establishing the safe use of new technologies and therapies in interventional cardiovascular medicine. CRF is the sponsor of the Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Celebrating its 25th anniversary this year, TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine. For more information, visit http://www.crf.org and http://www.tctconference.com.
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.